1-9 of 9
D. Alberti
Close
Sort by
Journal Articles

Long-Term Treatment with the Once-Daily Oral Iron Chelator Deferasirox (Exjadereg], ICL670) Is Effective and Generally Well Tolerated in Pediatric Patients.

A. Piga, M. Bejaoui, Y. Kilinc, S. Perrotta, E. Vichinsky, C. Arrowsmith-Bensasson, E. Glimm, D. Alberti
Journal: Blood
Blood (2006) 108 (11): 1781.
https://doi.org/10.1182/blood.V108.11.1781.1781
Published: 2006
Journal Articles

Impact on Iron Removal of Dose Reduction for Non-Progressive Serum Creatinine Increases during Treatment with the Once-Daily, Oral Iron Chelator Deferasirox (Exjade®, ICL670).

N. Gattermann, N. Zoumbos, E. Angelucci, G. Drelichman, J. Siegel, E. Glimm, D. Alberti
Journal: Blood
Blood (2006) 108 (11): 3824.
https://doi.org/10.1182/blood.V108.11.3824.3824
Published: 2006
Journal Articles

Long-Term Effects of Deferasirox (Exjade®, ICL670) on Serum Ferritin: Outcome of Dose Adjustments in Achieving Maintenance or Reduction in Body Iron Stores.

J.B. Porter, A. Cohen, L. Agaoglu, A. Ganser, M.D. Cappellini, H. Maseruka, E. Glimm, D. Alberti
Journal: Blood
Blood (2006) 108 (11): 1769.
https://doi.org/10.1182/blood.V108.11.1769.1769
Published: 2006
Journal Articles

Satisfaction and Convenience of Chelation Therapy in Patients with Sickle Cell Disease (SCD): Comparison between Deferasirox (Exjade ® , ICL670) and Deferoxamine (DFO).

E. Vichinsky, R. Fischer, Z. Pakbaz, O. Onyekwere, J. Porter, P. Swerdlow, T. Coates, P. Lane, B. Files, B.U. Mueller, L. Coïc, G. Forni, L. Abetz, J.F. Baladi, C. Ressayre-Djaffer, I. Gathmann, D. Alberti, P. Marks
Journal: Blood
Blood (2005) 106 (11): 2334.
https://doi.org/10.1182/blood.V106.11.2334.2334
Published: 2005
Journal Articles

Comparison of LIC Obtained from Biopsy, BLS and R 2 -MRI in Iron Overloaded Patients with β-Thalassemia, Treated with Deferasirox (Exjade®, ICL670).

A. Piga, R. Fischer, P. Harmatz, T. G. St. Pierre, F. Longo, E. Fung, R. Engelhardt, S. Perrotta, R. Galanello, M. Capra, E. Vichinsky, G. Janka-Schaub, G. Masera, P. Cianciulli, T. Coates, G. Janssen, M. Jeng, M. E. Lai, G. Salles, P. Cole, D. Alberti, G. Rosenkranz, H. Opitz
Journal: Blood
Blood (2005) 106 (11): 2689.
https://doi.org/10.1182/blood.V106.11.2689.2689
Published: 2005
Journal Articles

Deferasirox (Exjade®, ICL670) Demonstrates Dose-Related Effects on Body Iron Levels Related to Transfusional Iron Intake in Transfusion-Dependent Anemia.

P. Greenberg, G. Dine, A. Ganser, G. Verhoef, L. DeBusscher, G. Quarta, P. Zachée, G. Alimena, M. Jeng, G. Tchernia, I. Gathmann, D. Alberti, B. Rabault
Journal: Blood
Blood (2005) 106 (11): 2694.
https://doi.org/10.1182/blood.V106.11.2694.2694
Published: 2005
Journal Articles

A Randomized, Controlled Phase II Trial in Sickle Cell Disease Patients with Chronic Iron Overload Demonstrates That the Once-Daily Oral Iron Chelator Deferasirox (Exjade ® , ICL670) Is Well Tolerated and Reduces Iron Burden.

E. Vichinsky, R. Fischer, E. Fung, O. Onyekwere, J. Porter, P. Swerdlow, T. Coates, P. Lane, B. Files, B. U. Mueller, F. Bernaudin, G. L. Forni, C. Ressayre-Djaffer, I. Gathmann, J. Holland, D. Alberti, P. Marks
Journal: Blood
Blood (2005) 106 (11): 313.
https://doi.org/10.1182/blood.V106.11.313.313
Published: 2005
Journal Articles

Effect of Iron Intake on Control of Body Iron in Patients with Thalassemia Major Treated with Deferasirox (Exjade®, ICL670).

A. Cohen, G. Masera, N. Zoumbos, Z. Uysal, D. Boulet, N. Watman, S. Loggetto, H. Opitz, I. Gathmann, D. Alberti
Journal: Blood
Blood (2005) 106 (11): 822.
https://doi.org/10.1182/blood.V106.11.822.822
Published: 2005
Journal Articles

Iron Chelation Therapy with Deferasirox (Exjade®, ICL670) or Deferoxamine Results in Reduced Hepatocellular Inflammation and Improved Liver Function in Patients with Transfusion-Dependent Anemia.

P. Brissot, B. Turlin, G.L. Forni, G. Alimena, G. Quarta, D. Selleslag, A. Thompson, F. Locatelli, A. Berretta, M. de Montalembert, C. Ressayre-Djaffer, B. Rabault, J. Ford, D. Alberti
Journal: Blood
Blood (2005) 106 (11): 823.
https://doi.org/10.1182/blood.V106.11.823.823
Published: 2005